期刊文献+

抗乙型肝炎病毒药物研发现状 被引量:4

Advances in drug research and development for the treatment of chronic hepatitis B
下载PDF
导出
摘要 从1983年到2005年11月,被美国FDA批准用于慢性乙型肝炎治疗的有5种药物,但其在疗效和不良反应等方面均有一定的局限性。目前,一批用于治疗慢性乙型肝炎的新药正处于研发阶段,其中已进入临床试验后期的药物以核苷类似物为主。本文对已上市及进入临床试验的治疗乙型肝炎的药物进行了总结,并对已完成Ⅱ期临床试验的治疗慢性乙型肝炎的药物进行了评述。 There were five drugs for the treatment of chronic hepatitis B approved by U. S. Food and Drug Administration (FDA) from 1983 to November 2005. However, their therapeutic limitations and side effects bring about the needs of new drug development. In this article, the drugs approved by FDA for treating chronic hepatitis B virus infection, as well as those under clinical trials, and the three drugs whose phase-2 clinical trials have been completed are reviewed.
作者 陈大明 肖宏
出处 《药学服务与研究》 CAS CSCD 2006年第3期193-196,共4页 Pharmaceutical Care and Research
关键词 肝炎 乙型 慢性 抗病毒药 核苷类似物 干扰素类 hepatitis B, chronic antiviral agents, nucleoside analogue interferon
  • 相关文献

参考文献19

  • 1World Health Organization.Hepatitis B[EB/OL].United Nations:World Health Organization,2000[2005-10-12].http://www.who.int/mediacentre/factsheets /fs204/en/index.html.
  • 2U.S.Food and Drug Administration (FDA).Drug@ FDA[EB/OL].Maryland,U.S.:Food and Drug Administration,2005[2005-11-20].http://www.accessdata.fda.gov/scripts/cder/drugsatfda/.
  • 3WONG D K H,CHEUNG A M,O'ROURKE K,et al.Effect of alpha-interferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B[J].Ann Intern Med,1993,119(4):312-323.
  • 4HUI A Y,CHAN H L-Y,CHEUNG A Y-K,etal.Systematic review:treatment of chronic hepatitis B virus infection by pegylated interferon[J].Aliment Pharmacol Ther,2005,22(6):519-528.
  • 5LAI C L,CHIEN R N,LEUNG N W Y,et al.A one-year trial of lamivudine for chronic hepatitis B[J].N Engl J Med,1998,339(2):61-68.
  • 6ALLEN M I,DESLAURIERS M,ANDREWS C W,et al.Identification and characterization of mutations in hepatitis B virus resistant to lamivudine[J].Hepatology,1998,27 (6):1670-1677.
  • 7MARCELLIN P,CHANG T T,LIM S G,et al.Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B[J].N Engl J Med,2003,348 (9):808-816.
  • 8RIVKIN A.A review of entecavir in the treatment of chronic hepatitis B infection[J].Curr Med Res Opin,2005,21 (11):1845-1856.
  • 9U.S.National Institutes of Health (developed by the National Library of Medicine).Information on clinical trials and human research studies[EB/OL].Maryland,U.S.:U.S.National Library of Medicine,2005[2005-12-01].http://www.clinicaltrials.gov/.
  • 10Novelos Therapeutics,Inc.Our lead products:BAM-205[EB/OL].Massachusetts,U.S.:Novelos Therapeutics,Inc.,2005[2005-12-10].http://www.novelos.com/html/our_products/BAM_205.btm.

同被引文献42

引证文献4

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部